Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this study is to assess the efficacy and safety of Camrelizumab plus chemotherapy in the treatment of adult participants with medically inoperable Stage I or IIA non-small cell lung cancer (NSCLC).
Epistemonikos ID: ba9eb619f02a4bb845bff00fe3721178f07ddfeb
First added on: May 07, 2024